102 related articles for article (PubMed ID: 9082695)
21. [Effect of estrogen and progesterone on the expression of VEGF mRNA in epithelial ovarian cancer cell line].
Li H; Sun H
Zhonghua Zhong Liu Za Zhi; 2004 May; 26(5):264-7. PubMed ID: 15312358
[TBL] [Abstract][Full Text] [Related]
22. Anti-proliferative activity of natural interferon-alpha, isotretinoin and their combination varies in different human melanoma cell lines.
Schaber B; Mayer P; Schreiner T; Rassner G; Fierlbeck G
Melanoma Res; 1994 Oct; 4(5):319-26. PubMed ID: 7858417
[TBL] [Abstract][Full Text] [Related]
23. beta-Sitosterol enhances tamoxifen effectiveness on breast cancer cells by affecting ceramide metabolism.
Awad AB; Barta SL; Fink CS; Bradford PG
Mol Nutr Food Res; 2008 Apr; 52(4):419-26. PubMed ID: 18338406
[TBL] [Abstract][Full Text] [Related]
24. Antiproliferative effects of 5-fluorouracil and interferon-alpha in combination on a hepatocellular carcinoma cell line in vitro and in vivo.
Kojiro S; Yano H; Ogasawara S; Momosaki S; Takemoto Y; Nishida N; Kojiro M
J Gastroenterol Hepatol; 2006 Jan; 21(1 Pt 1):129-37. PubMed ID: 16706824
[TBL] [Abstract][Full Text] [Related]
25. Medroxyprogesterone acetate inhibits interleukin 6 secretion from KPL-4 human breast cancer cells both in vitro and in vivo: a possible mechanism of the anticachectic effect.
Kurebayashi J; Yamamoto S; Otsuki T; Sonoo H
Br J Cancer; 1999 Feb; 79(3-4):631-6. PubMed ID: 10027341
[TBL] [Abstract][Full Text] [Related]
26. Effect of vitamin E on tamoxifen-treated breast cancer cells.
Peralta EA; Viegas ML; Louis S; Engle DL; Dunnington GL
Surgery; 2006 Oct; 140(4):607-14; discussion 614-5. PubMed ID: 17011908
[TBL] [Abstract][Full Text] [Related]
27. The expression and action of granulocyte macrophage-colony stimulating factor and its interaction with TGF-beta in endometrial carcinoma.
Ripley D; Tang XM; Ma C; Chegini N
Gynecol Oncol; 2001 May; 81(2):301-9. PubMed ID: 11330966
[TBL] [Abstract][Full Text] [Related]
28. Proteasome inhibitors and their combination with antiandrogens: effects on apoptosis, cellular proliferation and viability of prostatic adenocarcinoma cell cultures.
Zwergel T; Tahmatzopoulos A; Wullich B; Zwergel U; Stöckle M; Unteregger G
Prostate Cancer Prostatic Dis; 2004; 7(2):138-43. PubMed ID: 15069423
[TBL] [Abstract][Full Text] [Related]
29. Effect of liposome-encapsulated alpha- or beta-interferon on breast cancer cell lines.
Coradini D; Pellizzaro C; Biffi A; Lombardi L; Pirronello E; Riva L; Di Fronzo G
Anticancer Res; 1998; 18(1A):177-82. PubMed ID: 9568074
[TBL] [Abstract][Full Text] [Related]
30. Development of cross-resistance to tamoxifen in raloxifene-treated breast carcinoma cells.
Gao ZO; Gao ZP; Fields JZ; Boman BM
Anticancer Res; 2002; 22(3):1379-83. PubMed ID: 12168814
[TBL] [Abstract][Full Text] [Related]
31. Synergistic antitumor effects of a combination of interferons and retinoic acid on human tumor cells in vitro and in vivo.
Lindner DJ; Borden EC; Kalvakolanu DV
Clin Cancer Res; 1997 Jun; 3(6):931-7. PubMed ID: 9815768
[TBL] [Abstract][Full Text] [Related]
32. Stronger growth-inhibitory effect of interferon (IFN)-beta compared to IFN-alpha is mediated by IFN signaling pathway in hepatocellular carcinoma cells.
Damdinsuren B; Nagano H; Wada H; Kondo M; Ota H; Nakamura M; Noda T; Natsag J; Yamamoto H; Doki Y; Umeshita K; Dono K; Nakamori S; Sakon M; Monden M
Int J Oncol; 2007 Jan; 30(1):201-8. PubMed ID: 17143530
[TBL] [Abstract][Full Text] [Related]
33. Inhibition of murine renal carcinoma pulmonary metastases by systemic administration of interferon gamma: mechanism of action and potential for combination with interleukin 4.
Hillman GG; Younes E; Visscher D; Hamzavi F; Kim S; Lam JS; Montecillo EJ; Ali E; Pontes JE; Puri RK; Haas GP
Clin Cancer Res; 1997 Oct; 3(10):1799-806. PubMed ID: 9815566
[TBL] [Abstract][Full Text] [Related]
34. Medroxyprogesterone and tamoxifen augment anti-proliferative efficacy and reduce mitochondria-toxicity of epirubicin in FM3A tumor cells in vitro.
Altinoz MA; Bilir A; Gedikoglu G; Ozcan E; Oktem G; Muslumanoglu M
Cell Biol Int; 2007 May; 31(5):473-81. PubMed ID: 17198756
[TBL] [Abstract][Full Text] [Related]
35. Steroid receptors and response of endometrial cancer to hormones in vitro.
Grönroos M; Mäenpää J; Kangas L; Erkkola R; Paul R; Grenman S
Ann Chir Gynaecol Suppl; 1987; 202():76-9. PubMed ID: 2959189
[TBL] [Abstract][Full Text] [Related]
36. Mechanism of antitumoral activity of medroxyprogesterone acetate for endometrial cancer.
Fujimoto J; Fujita H; Hosoda S; Okada H
Nihon Sanka Fujinka Gakkai Zasshi; 1989 Nov; 41(11):1836-40. PubMed ID: 2531782
[TBL] [Abstract][Full Text] [Related]
37. Effect of medroxyprogesterone acetate (MPA) and serum factors on cell proliferation in primary cultures of an MPA-induced mammary adenocarcinoma.
Dran G; Luthy IA; Molinolo AA; Montecchia F; Charreau EH; Pasqualini CD; Lanari C
Breast Cancer Res Treat; 1995 Aug; 35(2):173-86. PubMed ID: 7647339
[TBL] [Abstract][Full Text] [Related]
38. [Hormone dependence of malignant ovarian tumors--an in vitro model].
Schieder K; Bieglmayer C; Kölbl H
Geburtshilfe Frauenheilkd; 1989 May; 49(5):437-41. PubMed ID: 2544477
[TBL] [Abstract][Full Text] [Related]
39. [Antiproliferative actions of medroxyprogesterone acetate (MPA) to human ovarian cancer cell lines in vitro].
Kiyozuka Y; Ito K; Nakano S; Tamori N; Adachi S; Noda T; Yoshida M; Imai S
Nihon Sanka Fujinka Gakkai Zasshi; 1992 Feb; 44(2):137-44. PubMed ID: 1312110
[TBL] [Abstract][Full Text] [Related]
40. Natural interferon-alpha activity in hormone-sensitive, hormone-resistant and autonomous human breast-cancer cell lines.
Iacopino F; Robustelli della Cuna G; Sica G
Int J Cancer; 1997 Jun; 71(6):1103-8. PubMed ID: 9185717
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
